ranolazine has been researched along with Extrasystole, Ventricular in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dale, RA; Haigney, MC; Krantz, MJ; Schuller, JL; Yeung, E | 1 |
| Freudenberger, R; Levin, V; Martinez, MW; Nanda, S | 1 |
| Belardinelli, L; Braunwald, E; Hedgepeth, CM; Karwatowska-Prokopczuk, E; Morrow, DA; Qin, J; Scirica, BM; Spinar, J; Verheugt, FW; Wang, W | 1 |
| Antzelevitch, C; Belardinelli, L; Glass, A; Goodrow, RJ; Sicouri, S; Timothy, KW; Zygmunt, AC | 1 |
1 trial(s) available for ranolazine and Extrasystole, Ventricular
| Article | Year |
|---|---|
Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thr
Topics: Acetanilides; Acute Coronary Syndrome; Death, Sudden, Cardiac; Electrocardiography; Enzyme Inhibitors; Follow-Up Studies; Humans; Incidence; Myocardial Infarction; Piperazines; Placebos; Prognosis; Proportional Hazards Models; Ranolazine; Risk Factors; Tachycardia, Ventricular; Thrombolytic Therapy; Ventricular Premature Complexes | 2010 |
3 other study(ies) available for ranolazine and Extrasystole, Ventricular
| Article | Year |
|---|---|
Ranolazine for the suppression of ventricular arrhythmia: a case series.
Topics: Acetanilides; Adult; Aged; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Piperazines; Ranolazine; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2014 |
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetanilides; Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Agonists; Disease Models, Animal; Dogs; Electrocardiography; Endocardium; Enzyme Inhibitors; Heart Ventricles; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Pericardium; Piperazines; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes | 2007 |